These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 5852632)
1. [Experiences with desacetyl-lanatoside C in treatment and in preparation for surgery of surgical heart disease patients]. Stocco M; Grasso A Minerva Chir; 1965 Sep; 20(17):757-64. PubMed ID: 5852632 [No Abstract] [Full Text] [Related]
3. [Clinical study of a new cardiotonic drug, desacetyl-lanatoside C]. Warembourg H; Bertrand ME; Ducloux G Lille Med; 1972 Feb; 17():Suppl 2:169-72. PubMed ID: 5034397 [No Abstract] [Full Text] [Related]
4. [Clinical experiences with desacetyl-lanatoside-C]. De Lutterotti A Clin Ter; 1965 Aug; 34(4):300-7. PubMed ID: 5321635 [No Abstract] [Full Text] [Related]
6. [On the use of desacetyl-lanatoside C in therapy of uncompensated heart diseases. Clinical contribution]. Vercillo L; Rossi C; Vergallo L Minerva Med; 1965 Sep; 56(74):3172-5. PubMed ID: 5319422 [No Abstract] [Full Text] [Related]
7. [The bradycardiac effect of oral administration of an overload of desacetyl-lanatoside C]. Pavesi V; Bianchi G Minerva Med; 1966 Jun; 57(45):2075-8. PubMed ID: 5939220 [No Abstract] [Full Text] [Related]
8. [Diacetyl-lanatoside C in the therapy of cardio-circulatory decompensation in the aged]. Franzini C; Turri C; Bernascone E G Gerontol; 1965 Dec; 13(12):1441-88. PubMed ID: 5880983 [No Abstract] [Full Text] [Related]
9. [On the advantages of the use of desacetyl-lanatoside C in cardiokinetic therapy]. De Magistris L; Menegazzo G Minerva Med; 1967 Feb; 58(13):482-8. PubMed ID: 6021619 [No Abstract] [Full Text] [Related]
10. [Influence of the maintenance dosage on urinary elimination of an average standard digitalization dose of tritiated desacetyl-lanatoside C in normal subjects and in fibrillating cardiopathic subjects]. Damascelli B; Roncoroni L; Cova N; Pavesi V; Bianchi G Minerva Cardioangiol; 1967 Jun; 15(6):398-403. PubMed ID: 6056084 [No Abstract] [Full Text] [Related]
11. [Clinical study of a new digitalic drug: desacetyl-lanatoside C]. Faivre G; Djaidane A Therapeutique; 1972 Feb; 48(2):111-5. PubMed ID: 5049320 [No Abstract] [Full Text] [Related]
12. [Treatment of cardiac insufficiency with lanatigen C]. Tomov L; Orbetsov M; Tomov I; Todorova M; Visheva N Vutr Boles; 1979; 18(3):181-90. PubMed ID: 475894 [No Abstract] [Full Text] [Related]
13. [Effectiveness of the use of desacetyl-lanatoside C in the treatment of cardiac insufficiency]. Bersi M; Bocchiola M Minerva Cardioangiol; 1970 Jul; 18(7):449-56. PubMed ID: 5510027 [No Abstract] [Full Text] [Related]
14. [On the use of the preparation Cedilanid with theophylline on the aging heart]. Stowasser I Wien Med Wochenschr; 1967 Jun; 117(22):563-5. PubMed ID: 6078465 [No Abstract] [Full Text] [Related]
15. [Cardiac glycosides in surgery]. Kraft-Kinz J Med Klin; 1966 Sep; 61(35):1386-9. PubMed ID: 5998592 [No Abstract] [Full Text] [Related]